These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 11817007

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO, Onakoya AO, Olasimbo OO, Adefule AK.
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
    Nicoară S.
    Oftalmologia; 2001 Mar; 52(2):81-4. PubMed ID: 11771108
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
    Purello D'Ambrosio F, Gangemi S, Ricciardi L, Cuzzocrea S, Di Lorenzo G.
    Allergol Immunopathol (Madr); 1997 Mar; 25(5):233-7. PubMed ID: 9395007
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of local acetylcysteine and artificial tears in the management of dry eye syndrome].
    Pokupec R, Petricek I, Sikić J, Bradić M, Popović-Suić S, Petricek G.
    Acta Med Croatica; 2005 Mar; 59(4):337-40. PubMed ID: 16334742
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
    Wilson SE, Perry HD.
    Ophthalmology; 2007 Jan; 114(1):76-9. PubMed ID: 17070588
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
    Salib GM, McDonald MB, Smolek M.
    J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
    Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M, Okada N, Igarashi A, Kujira A, Fujishima H, Okamoto S, Shimazaki J, Tsubota K.
    Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S, Schiavone M, Bonini S, Magrini L, Lischetti P, Lambiase A, Bucci MG.
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [Abstract] [Full Text] [Related]

  • 19. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes].
    Lee S, Dausch S, Maierhofer G, Dausch D.
    Klin Monbl Augenheilkd; 2004 Oct; 221(10):825-36. PubMed ID: 15499517
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease.
    Rao SN, Rao RD.
    Cornea; 2006 Jul; 25(6):674-8. PubMed ID: 17077659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.